Cost-effectiveness of first-v.second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy
- Linda M. Davies*
- , Shôn Lewis
- , Peter B. Jones
- , Thomas R.E. Barnes
- , Fiona Gaughran
- , Karen Hayhurst
- , Alison Markwick
- , Helen Lloyd
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review